Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,735
Closed -$354K 348
2022
Q4
$354K Hold
4,735
0.09% 216
2022
Q3
$306K Buy
4,735
+200
+4% +$13.9K 0.09% 224
2022
Q2
$324K Buy
4,535
+361
+9% +$26.8K 0.08% 229
2022
Q1
$321K Sell
4,174
-4,778
-53% -$344K 0.08% 241
2021
Q4
$685K Buy
8,952
+97
+1% +$7.13K 0.2% 134
2021
Q3
$654K Sell
8,855
-460
-5% -$34.5K 0.21% 129
2021
Q2
$621K Buy
9,315
+3,336
+56% +$223K 0.21% 139
2021
Q1
$445K Buy
+5,979
New +$454K 0.17% 165

Other funds holding HOLX

Bay Colony Advisors's HOLX Position: Q1 2023 in Review

Bay Colony Advisors sold out of Hologic (HOLX) in Q1 2023, closing a stake of 4,735 shares — an estimated $354K sold.

Bay Colony Advisors first reported a position in HOLX in Q1 2021 and held it in 8 quarters. The position peaked at $685K in Q4 2021. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Bay Colony Advisors reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • Bay Colony Advisors sold 4,735 Hologic shares in Q1 2023, an estimated $354K.
  • Bay Colony Advisors first reported a position in Hologic in Q1 2021 and held it in 8 quarters.
  • Bay Colony Advisors's Hologic position peaked at $685K in Q4 2021.
  • 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Bay Colony Advisors's 13F filing for Q1 2023, filed 27 Apr 2023.